News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Clears Roche (RHHBY) For Failing To Report Side Effects


11/19/2013 6:55:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

After spending a year investigating Roche for a failure to report tens of thousands of adverse events in connection with various drugs, the European Medicines Agency has concluded its review and “has not identified any important new safety concerns.”

“The balance of benefits and risks of these medicines has not been affected and there is no new advice regarding their use,” the EMA says in a statement. The regulator adds that Roche is expected to ensure such data are included and considered in routine pharmacovigilance activities, though. The so-called “infringement procedure” was conducted by the agency’s Pharmacovigilance Risk Assessment Committee.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at ABC News
Read at Washington Post
Read at Ottawa Citizen
Read at Pharmalot


comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES